CDX2 and colorectal adenocarcinoma: We also evaluated the sensitivity, specificity, positive predictive value, and negative predictive value of CDX2 expression and CK7-/CK20+ immunophenotype to differentiate colorectal adenocarcinoma from pancreatic and gastric adenocarcinomas (Table 4).